Nachrichten zur Bristol-Myers Squibb Co. Aktie

S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven by Strong AI Demand And Margin Expansion - Apple (NASDAQ:AAPL), Bristol-Myers Squibb (NYSE:BMY)

Goldman Sachs raises S&P 500s EPS forecast to $268 in 2025, driven by AI tech demand & semiconductor recovery. Margin…

Bristol Myers Squibb: A High-Yield Bargain With Growth On The Horizon

…

Bristol-Myers Squibb Aktie: Neue Blockbuster-Hoffnung

Kulmbach (www.aktiencheck.de) - Bristol-Myers Squibb-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Bristol Myers Squibb nach "bahnbrechender" Zulassung: Aktie erwacht zum Leben

Mit der Aktie des amerikanischen Pharma-Unternehmens Bristol Myers Squibb ließ sich in den zurückliegenden Quartalen wenig Geld verdienen. Ausgehend vom…

Bristol Myers Squibb nach "bahnbrechender" Zulassung: Aktie erwacht zum Leben

Mit der Aktie des amerikanischen Pharma-Unternehmens Bristol Myers Squibb ließ sich in den zurückliegenden Quartalen wenig Geld verdienen. Ausgehend vom…

PRME Stock Rises 11.8% on Collaboration With Bristol Myers

Prime Medicine collaborates with Bristol Myers Squibb for the development of T-cell therapies. Shares gain.…

Bristol-Myers Squibb Aktie: FDA-Zulassung von COBENFY bringt Aufschwung

Toronto (www.aktiencheck.de) - Bristol-Myers Squibb-Aktienanalyse von BMO Capital Markets: Rating und Kursziel BMO Capital Markets hat das Kursziel für die Aktie des…

Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval

…

Dow notches record close after tame inflation report

STORY: U.S. stocks ended mixed on Friday, with the Dow notching a record closing high and all three indexes logging…

Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)

…

Opening Bell: Wall Street vor weiteren Gewinnen; Bristol-Myers Squibb, Las Vagas Sands, Wynn Resorts, Paypal, Nike im Fokus

Die US-Börsen steuern nach der jüngsten Rekordjagd am Freitag auf weitere Gewinne zu. Preisdaten gaben den Aktienkursen moderat positive Impulse.…

Stocks making the biggest moves premarket: Bristol-Myers Squibb, Costco, Super Micro Computer and more

These are the stocks posting the largest moves in premarket trading.…

Bristol-Myers Squibb stock gains on FDA approval of schizophrenia treatment By Investing.com

Bristol-Myers Squibb stock gains on FDA approval of schizophrenia treatment…

Costco dips premarket; Bristol-Myers Squibb, Wynn Resorts rise By Investing.com

Costco dips premarket; Bristol-Myers Squibb, Wynn Resorts rise…

Bristol-Myers Squibb: Unlocking Value With KarXT FDA Approval And Oncology Pipeline Progress

…

Bristol Myers Squibb shares move higher on FDA approval of schizophrenia drug

Bristol Myers Squibb Co (NYSE:BMY, ETR:RM, OTC:BMYMP) shares moved higher after the pharmaceutical company’s schizophrenia drug was approved by the…

US drug regulator approves the first new schizophrenia drug in 30 years

The US Food and Drug Administration (FDA) has approved Cobenfy, the first new drug for schizophrenia in over 30 years, developed…

FDA approves Bristol Myers Squibbs schizophrenia drug, the first new type of treatment in decades

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S.…

Bristol-Myers Squibb Aktie: Spannung vor FDA-Entscheidung zu KarXT

Die Spannung steigt bei Bristol-Myers Squibb (BMY) vor der anstehenden FDA-Entscheidung zum Schizophrenie-Medikament KarXT am 26. September. Das innovative Präparat,…

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…

Bristol-Myers Squibb Company PFD CONV 2 declares $0.50 dividend

…

Bristol-Myers Squibb declares $0.60 dividend

…

Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely Prolonged

…

Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade)

…

Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025

…

Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript)

…

Global Hematologic Malignancies Market Size To Worth USD 144.58 Billion By 2033 | CAGR Of 7.97%

The Global Hematologic Malignancies Market Size was Valued at USD 67.18 Billion in 2023 and the Worldwide Hematologic Malignancies Market…

Bristol-Myers Squibb Company (BMY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)

…

2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High

Rebounding growth could make shares of this leading drugmaker a big winner.…

2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High

…

How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb Stock

…

Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO By Reuters

Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO…

Billion-dollar Deals in Radiopharmaceuticals Catch Investor Attention

Recent mergers and acquisitions and partnership deals in the medical industry are showing signs of increasing investor interest in the…

Where Will Bristol Myers Squibb Be in 5 Years?

The drugmaker will go through key changes by the end of the decade.…

Evotec: Diese Zahlung von Bristol Myers Squibb treibt die Aktie an

Evotec erhält 75 Millionen Dollar von Bristol Myers Squibb für Fortschritte in der Krebsforschung.…

Evotec erhält 75 Millionen Dollar Meilensteinzahlung von Bristol Myers Squibb

HAMBURG (dpa-AFX) - Evotec hat in seiner Partnerschaft mit dem US-Pharmaunternehmen Bristol-Myers Squibb Fortschritte erzielt und so Meilensteinzahlungen…

EQS-News: Evotec verkündet starke Fortschritte in strategischer Partnerschaft mit Bristol Myers Squibb im Bereich Protein Degradation (deutsch)

Evotec verkündet starke Fortschritte in strategischer Partnerschaft mit Bristol Myers Squibb im Bereich Protein Degradation^EQS-News: Evotec SE / Schlagwort(e): SonstigesEvotec…

Bristol Myers Squibb Witnesses Strong Demand For Newer Drugs As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast

…

dpa-AFX ProFeed